Freespira (formerly Palo Alto Health Sciences), an FDA-cleared wireless digital therapeutic system for individuals who have panic disorder, panic attacks, and other panic symptoms, completed

Freespira (formerly Palo Alto Health Sciences), an FDA-cleared wireless digital therapeutic system for individuals who have panic disorder, panic attacks, and other panic symptoms, completed
mHealth companies are witnessing a significant surge in funding amid the COVID-19 pandemic. mHealth companies raised nearly $2 billion in the first nine months (9M)
AliveCor, an AI-enabled (medical-grade) mobile electrocardiogram device, raised $65 million in a Series E financing round led by existing investors OMRON, Khosla Ventures, WP Global
Eko Health, a developer of AI-enabled smart stethoscope that detects structural heart disease signs, atrial fibrillation, low ejection fraction, and other hemodynamic parameters indicative of
Augmedix, a provider of apps for Google Glass that allows doctors to capture audio-visual data from the doctor-patient interaction and turn it into an EHR
Koneksa, the developer of a digital mobile biomarker platform that captures, monitors, and analyzes patient-generated data and outcomes in clinical studies, announced the completion of a
Emme, a birth control pills tracking smart case for women, raised $2.5 million in seed funding led by Magnetic Ventures with participation from existing investors.
One Drop, a digital therapeutics provider for (diabetes and other chronic conditions) for people living with diabetes, pre-diabetes, high blood pressure, and high cholesterol, raised
Medtronic, an Irish-domiciled medical device company, agreed to acquire Companion Medical, manufacturer of InPen – an FDA-cleared smart insulin pen system paired with an integrated
DarioHealth, the developer of app-connected blood glucose monitoring system, closed a private placement of $28.6 million from accredited investors, including healthcare funds and institutions from